Product Description: Rozanolixizumab (UCB7665), a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Smith B, et al. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration. MAbs. 2018;10(7):1111-1130.
CAS Number: 1584645-37-3
Molecular Weight: N/A
Compound Purity: 99.34
Research Area: Inflammation/Immunology
Solubility: H2O
Target: Others